Match tier Listed
Presence Formerly Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Edita M. Newton

Resident Physician

Formerly Arkansas Affiliated with UAMS through 2022; recent publications list Indiana University School of Medicine.

1 h-index 1 pubs 35 cited

  • Humans
  • Dermatitis, Atopic
  • Skin Diseases
  • Antineoplastic Agents
  • Urinary Bladder Neoplasms
  • Carcinoma, Transitional Cell
  • Middle Aged
  • Nail Diseases
  • Pyrazoles
  • Quinoxalines
  • Protein Kinase Inhibitors
  • Dermatitis, Exfoliative
  • Graft vs Host Disease
  • Paraneoplastic Syndromes
  • Thymoma

Biography and Research Information

OverviewAI-generated summary

Edita M. Newton's research has focused on dermatologic conditions and the adverse effects of cancer therapies. Newton has investigated the aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signaling pathway as a potential therapeutic target for atopic dermatitis. Additionally, Newton has documented the adverse dermatologic effects of erdafitinib, an antineoplastic agent, in a patient with metastatic urothelial carcinoma. Other research interests include graft-versus-host disease-like erythroderma as a paraneoplastic disorder, infantile hemangiomas, and nail diseases.

Metrics

  • h-index: 1
  • Publications: 1
  • Citations: 35

Positions

  • Resident Physician 2018–present
    University of Arkansas for Medical Sciences Dermatology ORCID

Selected Publications

  • Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis (2022)
    Experimental Dermatology 45 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

3 Collaborators 4 Institutions 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics